Nexien BioPharma Inc (NXEN)
0.0180
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Nexien BioPharma Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 29, 2021 | 186.74 |
| June 28, 2021 | 186.74 |
| June 25, 2021 | 186.47 |
| June 24, 2021 | 211.81 |
| June 23, 2021 | 258.76 |
| June 22, 2021 | 248.09 |
| June 21, 2021 | 213.41 |
| June 18, 2021 | 266.50 |
| June 17, 2021 | 290.51 |
| June 16, 2021 | 260.76 |
| June 15, 2021 | 266.77 |
| June 14, 2021 | 280.11 |
| June 11, 2021 | 290.78 |
| June 10, 2021 | 293.44 |
| June 09, 2021 | 240.09 |
| June 08, 2021 | 277.30 |
| June 07, 2021 | 250.76 |
| June 04, 2021 | 266.77 |
| June 03, 2021 | 236.89 |
| June 02, 2021 | 253.43 |
| June 01, 2021 | 262.63 |
| May 28, 2021 | 262.63 |
| May 27, 2021 | 306.78 |
| May 26, 2021 | 288.38 |
| May 25, 2021 | 306.78 |
| Date | Value |
|---|---|
| May 24, 2021 | 266.23 |
| May 21, 2021 | 226.75 |
| May 20, 2021 | 266.23 |
| May 19, 2021 | 266.23 |
| May 18, 2021 | 226.75 |
| May 17, 2021 | 246.76 |
| May 14, 2021 | 266.23 |
| May 13, 2021 | 246.76 |
| May 12, 2021 | 218.75 |
| May 11, 2021 | 216.08 |
| May 10, 2021 | 290.78 |
| May 07, 2021 | 362.27 |
| May 06, 2021 | 426.83 |
| May 05, 2021 | 320.12 |
| May 04, 2021 | 308.59 |
| May 03, 2021 | 308.59 |
| April 30, 2021 | 282.87 |
| April 29, 2021 | 374.16 |
| April 28, 2021 | 374.16 |
| April 27, 2021 | 360.02 |
| April 26, 2021 | 415.05 |
| April 23, 2021 | 370.95 |
| April 22, 2021 | 371.59 |
| April 21, 2021 | 385.74 |
| April 20, 2021 | 437.17 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.584
Minimum
May 21 2019
521.47
Maximum
Mar 04 2021
107.05
Average
21.79
Median
Dec 04 2019
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | 20.44 |
| iBio Inc | 0.7501 |
| Theriva Biologics Inc | 0.204 |
| Oragenics Inc | 6.627 |
Price to Book Value Related Metrics
| Price | 0.0180 |
| Earnings Yield | -46.67% |
| Market Cap | 1.211M |